A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany

Christina Bahrs; Miriam Kesselmeier; Martin Kolditz; Santiago Ewig; Gernot Rohde; Grit Barten-Neiner; Jan Rupp; Martin Witzenrath; Tobias Welte; Mathias W Pletz; CAPNETZ Study Group

doi:10.1183/13993003.02432-2021

A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany

Eur Respir J. 2022 Feb 3;59(2):2102432. doi: 10.1183/13993003.02432-2021. Print 2022 Feb.

Authors

Christina Bahrs^{1

2}, Miriam Kesselmeier³, Martin Kolditz⁴, Santiago Ewig⁵, Gernot Rohde^{6

7

8}, Grit Barten-Neiner^{7

8}, Jan Rupp^{8

9

10}, Martin Witzenrath^{8

11}, Tobias Welte^{7

8

12}, Mathias W Pletz^{13

8}; CAPNETZ Study Group

Affiliations

¹ Institute of Infectious Diseases and Infection Control, Jena University Hospital/Friedrich-Schiller-University, Jena, Germany.
² Dept of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
³ Institute of Medical Statistics, Computer and Data Sciences, Jena University Hospital/Friedrich-Schiller-University, Jena, Germany.
⁴ Division of Pulmonology, Medical Dept I, University Hospital Carl Gustav Carus, Dresden, Germany.
⁵ Thoraxzentrum Ruhrgebiet, Dept of Respiratory Medicine and Infectious Diseases, EVK Herne and Augusta Hospital, Bochum, Germany.
⁶ Medical Clinic I, Dept of Respiratory Medicine, University Hospital, Frankfurt/Main, Germany.
⁷ Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.
⁸ CAPNETZ STIFTUNG, Hannover, Germany.
⁹ Dept of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, Lübeck, Germany.
¹⁰ German Center for Infection Research (DZIF), partner site Hamburg-Lübeck-Borstel-Riems, Germany.
¹¹ Dept of Infectious Diseases and Pulmonary Medicine, and Division of Pulmonary Inflammation, Charité - Universitätsmedizin Berlin, Berlin, Germany.
¹² Dept of Pneumology, Hannover Medical School, Hannover, Germany.
¹³ Institute of Infectious Diseases and Infection Control, Jena University Hospital/Friedrich-Schiller-University, Jena, Germany mathias.pletz@med.uni-jena.de.

Abstract

In Germany, the recently approved 20-valent pneumococcal conjugate vaccine had a substantially higher coverage against pneumonia in adults than the 13-valent vaccine, while the coverage gap compared to the 23-valent polysaccharide vaccine was small https://bit.ly/3q4skov

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Germany
Heptavalent Pneumococcal Conjugate Vaccine
Humans
Pneumococcal Infections* / prevention & control
Pneumococcal Vaccines
Pneumonia, Pneumococcal* / prevention & control
Serogroup
Serotyping
Vaccines, Conjugate

Substances

Heptavalent Pneumococcal Conjugate Vaccine
Pneumococcal Vaccines
Vaccines, Conjugate